Lung Cancer Treatment Drugs Market Size And Share

  • Report Code : TIPRE00016887
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

폐암 치료제 시장 점유율 분석 및 기회 [2025-2031]

Buy Now

Lung Cancer Treatment Drugs Market Report Lung Cancer Treatment Drugs Market Scope and Analysis Lung Cancer Treatment Drugs Market Size and Share

Lung Cancer Treatment Drugs Market Report Analysis

Lung Cancer Treatment Drugs Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • AstraZeneca
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Sanofi
  • Boehringer Ingelheim International GmbH
  • Novartis AG
  • Merck and Co., Inc.

Regional Overview

  • 북미
  • 유럽
  • 아시아 태평양
  • 중남미
  • 중동 및 아프리카

Market Segmentation

By 종류 [비소세포폐암
  • NSCLC
  • 소세포폐암
By 약물 종류
  • 항대사제
  • 알킬화제
  • 유사분열 억제제
  • EGFR 억제제
  • 멀티키나제 억제제
  • 기타
By 유통채널
  • 병원 및 소매 약국
  • 온라인 유통
  • 기타
By 지리
  • 북미
  • 유럽
  • 아시아 태평양
  • 중남미